Activation of PIK3/akt is frequently involved in benign thyroid adenoma (BTA), follicular thyroid cancer (FTC) and anaplastic thyroid cancer (ATC) and progression from BTA to FTC to ATC[11]. Here, AKT1 is linked to thyroid gland follicular carcinoma.